tiprankstipranks
Autolus Therapeutics Shares Q1 Results and Corporate Update
Company Announcements

Autolus Therapeutics Shares Q1 Results and Corporate Update

Autolus Therapeutics Plc (AUTL) has issued an update.

On May 17, 2024, during its conference call to discuss the first quarter financial results, the Company will present an updated corporate presentation. This presentation, provided as part of a recent report, is intended solely for informational purposes and is not to be considered part of the official filed records for regulatory purposes. It will not be included in any past or future securities filings unless explicitly stated.

For detailed information about AUTL stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyAutolus Therapeutics to present three clinical data updates on obe-cel
GlobeNewswireAutolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
TipRanks Auto-Generated NewsdeskAutolus Therapeutics Shares Key FELIX Study Updates
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!